A detailed history of Kbc Group Nv transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 510 shares of KRYS stock, worth $90,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
510
Previous 473 7.82%
Holding current value
$90,213
Previous $84,000 11.9%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$153.12 - $183.64 $5,665 - $6,794
37 Added 7.82%
510 $94,000
Q4 2023

Feb 13, 2024

BUY
$96.0 - $128.29 $45,408 - $60,681
473 New
473 $59,000
Q4 2021

Feb 03, 2022

SELL
$39.81 - $88.24 $78,624 - $174,274
-1,975 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$37.03 - $60.0 $59,248 - $96,000
1,600 Added 426.67%
1,975 $82,000
Q4 2019

Feb 11, 2020

SELL
$33.17 - $65.23 $178,786 - $351,589
-5,390 Reduced 93.5%
375 $21,000
Q3 2019

Nov 07, 2019

BUY
$34.72 - $51.3 $86,452 - $127,737
2,490 Added 76.03%
5,765 $200,000
Q2 2019

Dec 03, 2019

BUY
$27.2 - $41.2 $89,080 - $134,930
3,275 New
3,275 $132,000
Q2 2019

Jul 30, 2019

SELL
$27.2 - $41.2 $89,080 - $134,930
-3,275 Closed
0 $0
Q1 2019

Dec 03, 2019

BUY
$19.86 - $32.9 $65,041 - $107,747
3,275 New
3,275 $108,000
Q1 2019

May 10, 2019

SELL
$19.86 - $32.9 $58,090 - $96,232
-2,925 Closed
0 $0
Q4 2018

Dec 03, 2019

BUY
$15.03 - $25.38 $43,962 - $74,236
2,925 New
2,925 $61,000
Q4 2018

Jan 31, 2019

SELL
$15.03 - $25.38 $33,441 - $56,470
-2,225 Closed
0 $0
Q3 2018

Dec 03, 2019

BUY
$14.43 - $21.0 $32,106 - $46,725
2,225 New
2,225 $39,000
Q3 2018

Nov 14, 2018

SELL
$14.43 - $21.0 $32,106 - $46,725
-2,225 Closed
0 $0
Q2 2018

Dec 03, 2019

BUY
$8.99 - $15.26 $20,002 - $33,953
2,225 New
2,225 $33,000
Q2 2018

Aug 03, 2018

SELL
$8.99 - $15.26 $20,002 - $33,953
-2,225 Closed
0 $0
Q1 2018

Dec 03, 2019

BUY
$8.61 - $11.74 $19,157 - $26,121
2,225 New
2,225 $22,000
Q1 2018

May 09, 2018

SELL
$8.61 - $11.74 $8,610 - $11,740
-1,000 Closed
0 $0
Q4 2017

Dec 03, 2019

BUY
$8.19 - $11.19 $8,189 - $11,190
1,000
1,000 $11,000

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.54B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.